MMP9 and respiratory failure: In line with these studies, the plasma samples analyzed in the present study showed that the levels of MMP-9 were similar between patients with post-COVID-19 syndrome and healthy subjects, suggesting that this matrix metalloproteinase may have limited utility as a long-term biomarker for predicting respiratory failure.